alcohol	Metoclopramide	4	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	6915
alcohol	Metoclopramide	4	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	6915
alcohol	Metoclopramide	4	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	6915
alcohol	Metoclopramide	4	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	6915
alcohol	Metoclopramide	4	5	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		none	6915	none	6915
alcohol	Metoclopramide	4	5	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		none	6915	none	6915
alcohol	Metoclopramide	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6915	none	6915
alcohol	Metoclopramide	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6915	none	6915
alcohol	metoclopramide	4	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	D008787
alcohol	metoclopramide	4	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	D008787
alcohol	metoclopramide	4	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	D008787
alcohol	metoclopramide	4	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		none	6915	none	D008787
alcohol	metoclopramide	4	5	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		none	6915	none	D008787
alcohol	metoclopramide	4	5	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		none	6915	none	D008787
alcohol	metoclopramide	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6915	none	D008787
alcohol	metoclopramide	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6915	none	D008787
alcohol	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	3008	none	3008
alcohol	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	3008	none	3008
alcohol	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	0	none	D013752
alcohol	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	0	none	D013752
alcohol	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6375	none	D007980
alcohol	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	6375	none	D007980
alcohol	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	3407	none	3407
alcohol	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	3407	none	3407
alcohol	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	448	none	D000431
alcohol	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	448	none	D000431
alcohol	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	161	none	161
alcohol	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		none	161	none	161
Metoclopramide	metoclopramide	1	1	false	none	7 DRUG INTERACTIONS    The effects of metoclopramide on gastrointestinal motility can impact the absorption of other drugs.  		6915	D008787
Metoclopramide	metoclopramide	1	3	false	none	7 DRUG INTERACTIONS    The effects of metoclopramide on gastrointestinal motility can impact the absorption of other drugs.  The known drug-drug interactions are listed below.  7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  		6915	D008787
Metoclopramide	metoclopramide	3	1	false	none	7 DRUG INTERACTIONS    The effects of metoclopramide on gastrointestinal motility can impact the absorption of other drugs.  The known drug-drug interactions are listed below.  7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  		6915	D008787
Metoclopramide	metoclopramide	3	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  		6915	D008787
Metoclopramide	metoclopramide	3	4	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		6915	D008787
Metoclopramide	metoclopramide	3	5	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		6915	D008787
Metoclopramide	metoclopramide	4	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		6915	D008787
Metoclopramide	metoclopramide	4	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  		6915	D008787
Metoclopramide	metoclopramide	4	5	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		6915	D008787
Metoclopramide	metoclopramide	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	D008787
Metoclopramide	metoclopramide	5	3	false	none	7.1 Anticholinergic and Narcotic Analgesic Drugs    The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.  Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		6915	D008787
Metoclopramide	metoclopramide	5	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		6915	D008787
Metoclopramide	metoclopramide	5	5	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  		6915	D008787
Metoclopramide	metoclopramide	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	D008787
Metoclopramide	metoclopramide	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	D008787
Metoclopramide	metoclopramide	6	4	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	D008787
Metoclopramide	metoclopramide	6	5	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	D008787
Metoclopramide	metoclopramide	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	D008787
Metoclopramide	metoclopramide	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	D008787
Metoclopramide	metoclopramide	7	5	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	D008787
Metoclopramide	metoclopramide	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	D008787
Metoclopramide	metoclopramide	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	D008787
Metoclopramide	metoclopramide	7	9	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	D008787
Metoclopramide	metoclopramide	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	D008787
Metoclopramide	metoclopramide	9	9	false	none	7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	D008787
Metoclopramide	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	6915	3008
Metoclopramide	cyclosporine	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3008	6915	3008
Metoclopramide	cyclosporine	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3008	6915	3008
Metoclopramide	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	6915	D013752
Metoclopramide	tetracycline	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	0	6915	D013752
Metoclopramide	tetracycline	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	0	6915	D013752
Metoclopramide	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	6915	D007980
Metoclopramide	levodopa	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	6375	6915	D007980
Metoclopramide	levodopa	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	6375	6915	D007980
Metoclopramide	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	6915	3407
Metoclopramide	digoxin	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3407	6915	3407
Metoclopramide	digoxin	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3407	6915	3407
Metoclopramide	Insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	Insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	Insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	Insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	Insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	Insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	Insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	Insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	6915	D000431
Metoclopramide	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	448	6915	D000431
Metoclopramide	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	448	6915	D000431
Metoclopramide	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	6915	161
Metoclopramide	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	161	6915	161
Metoclopramide	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	161	6915	161
Metoclopramide	insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	6915	5856
Metoclopramide	insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	6915	5856
Metoclopramide	insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
Metoclopramide	insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	6915	5856
metoclopramide	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3008	D008787	3008
metoclopramide	cyclosporine	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3008	D008787	3008
metoclopramide	cyclosporine	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3008	D008787	3008
metoclopramide	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	0	D008787	D013752
metoclopramide	tetracycline	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	0	D008787	D013752
metoclopramide	tetracycline	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	0	D008787	D013752
metoclopramide	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	6375	D008787	D007980
metoclopramide	levodopa	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	6375	D008787	D007980
metoclopramide	levodopa	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	6375	D008787	D007980
metoclopramide	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	3407	D008787	3407
metoclopramide	digoxin	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3407	D008787	3407
metoclopramide	digoxin	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	3407	D008787	3407
metoclopramide	Insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	Insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	Insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	Insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	Insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	Insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	Insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	Insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	448	D008787	D000431
metoclopramide	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	448	D008787	D000431
metoclopramide	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	448	D008787	D000431
metoclopramide	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	4	6	false	none	Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.  7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	5	6	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6915	161	D008787	161
metoclopramide	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	161	D008787	161
metoclopramide	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	161	D008787	161
metoclopramide	insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	5	7	false	none	7.2 Monoamine Oxidase Inhibitors    Metoclopramide has been shown to release catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients taking monoamine oxidase (MAO) inhibitors.  7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6915	5856	D008787	5856
metoclopramide	insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6915	5856	D008787	5856
metoclopramide	insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	insulin	9	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
metoclopramide	insulin	9	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  7.5 Antidepressants, Antipsychotics, and Neuroleptics    Concomitant use of metoclopramide should be avoided in patients taking antidepressants, antipsychotics, and/or neuroleptics that have been associated with  extrapyramidal reactions such as tardive dyskinesia or Neuroleptic Malignant Syndrome (NMS) that have occurred in association with metoclopramide [see Warnings and Precautions (5.2), (5.3) and Adverse Reactions (6.2)].  		6915	5856	D008787	5856
cyclosporine	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	0	3008	D013752
cyclosporine	tetracycline	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	0	3008	D013752
cyclosporine	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	6375	3008	D007980
cyclosporine	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	6375	3008	D007980
cyclosporine	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	3407	3008	3407
cyclosporine	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	3407	3008	3407
cyclosporine	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3008	5856	3008	5856
cyclosporine	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3008	5856	3008	5856
cyclosporine	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3008	5856	3008	5856
cyclosporine	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3008	5856	3008	5856
cyclosporine	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	448	3008	D000431
cyclosporine	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	448	3008	D000431
cyclosporine	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	161	3008	161
cyclosporine	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3008	161	3008	161
cyclosporine	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3008	5856	3008	5856
cyclosporine	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3008	5856	3008	5856
cyclosporine	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3008	5856	3008	5856
cyclosporine	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3008	5856	3008	5856
tetracycline	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	6375	D013752	D007980
tetracycline	levodopa	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	6375	D013752	D007980
tetracycline	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	3407	D013752	3407
tetracycline	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	3407	D013752	3407
tetracycline	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		0	5856	D013752	5856
tetracycline	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		0	5856	D013752	5856
tetracycline	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		0	5856	D013752	5856
tetracycline	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		0	5856	D013752	5856
tetracycline	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	448	D013752	D000431
tetracycline	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	448	D013752	D000431
tetracycline	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	161	D013752	161
tetracycline	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		0	161	D013752	161
tetracycline	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		0	5856	D013752	5856
tetracycline	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		0	5856	D013752	5856
tetracycline	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		0	5856	D013752	5856
tetracycline	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		0	5856	D013752	5856
levodopa	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	3407	D007980	3407
levodopa	digoxin	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	3407	D007980	3407
levodopa	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6375	5856	D007980	5856
levodopa	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6375	5856	D007980	5856
levodopa	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6375	5856	D007980	5856
levodopa	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6375	5856	D007980	5856
levodopa	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	448	D007980	D000431
levodopa	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	448	D007980	D000431
levodopa	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	161	D007980	161
levodopa	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		6375	161	D007980	161
levodopa	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6375	5856	D007980	5856
levodopa	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		6375	5856	D007980	5856
levodopa	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6375	5856	D007980	5856
levodopa	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		6375	5856	D007980	5856
digoxin	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3407	5856	3407	5856
digoxin	Insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3407	5856	3407	5856
digoxin	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3407	5856	3407	5856
digoxin	Insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3407	5856	3407	5856
digoxin	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3407	448	3407	D000431
digoxin	ethanol	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3407	448	3407	D000431
digoxin	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3407	161	3407	161
digoxin	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		3407	161	3407	161
digoxin	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3407	5856	3407	5856
digoxin	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		3407	5856	3407	5856
digoxin	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3407	5856	3407	5856
digoxin	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		3407	5856	3407	5856
Insulin	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		5856	448	5856	D000431
Insulin	ethanol	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		5856	448	5856	D000431
Insulin	ethanol	8	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	448	5856	D000431
Insulin	ethanol	8	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	448	5856	D000431
Insulin	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		5856	161	5856	161
Insulin	acetaminophen	7	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		5856	161	5856	161
Insulin	acetaminophen	8	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	161	5856	161
Insulin	acetaminophen	8	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	161	5856	161
Insulin	insulin	7	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		5856	5856
Insulin	insulin	7	8	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	5856
Insulin	insulin	8	7	false	none	7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	5856
Insulin	insulin	8	8	false	none	Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		5856	5856
ethanol	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		448	161	D000431	161
ethanol	acetaminophen	6	6	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  		448	161	D000431	161
ethanol	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		448	5856	D000431	5856
ethanol	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		448	5856	D000431	5856
ethanol	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		448	5856	D000431	5856
ethanol	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		448	5856	D000431	5856
acetaminophen	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		161	5856	161	5856
acetaminophen	insulin	6	7	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  		161	5856	161	5856
acetaminophen	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		161	5856	161	5856
acetaminophen	insulin	6	8	false	none	7.3 Drug Absorption    Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).  7.4 Insulin    Because the action of metoclopramide will hasten the movement of food to the intestines and therefore the rate of absorption, insulin dosage or timing of dosage may require adjustment.  Increasing movement of food to the intestines may lead to absorption of less glucose from a meal, hence less glucose in the circulation for a particular dose of administered insulin to act upon, resulting in hypoglycemia.  		161	5856	161	5856
